Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Depreciation and Depletion (2018 - 2024)

Historic Depreciation and Depletion for Bicycle Therapeutics (BCYC) over the last 7 years, with Q2 2024 value amounting to $1.6 million.

  • Bicycle Therapeutics' Depreciation and Depletion changed 0.0% to $1.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $6.6 million, marking a year-over-year increase of 1000.0%. This contributed to the annual value of $6.5 million for FY2023, which is 7567.57% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Depreciation and Depletion stood at $1.6 million for Q2 2024, which was down 0.0% from $1.7 million recorded in Q1 2024.
  • In the past 5 years, Bicycle Therapeutics' Depreciation and Depletion ranged from a high of $1.7 million in Q3 2023 and a low of $300000.0 during Q1 2020
  • For the 5-year period, Bicycle Therapeutics' Depreciation and Depletion averaged around $900000.0, with its median value being $500000.0 (2020).
  • Per our database at Business Quant, Bicycle Therapeutics' Depreciation and Depletion plummeted by 5000.0% in 2020 and then soared by 33333.33% in 2022.
  • Bicycle Therapeutics' Depreciation and Depletion (Quarter) stood at $400000.0 in 2020, then changed by 0.0% to $400000.0 in 2021, then skyrocketed by 275.0% to $1.5 million in 2022, then increased by 6.67% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
  • Its Depreciation and Depletion was $1.6 million in Q2 2024, compared to $1.7 million in Q1 2024 and $1.6 million in Q4 2023.